Get started
Author

Weixiao Kong

Institution: Shenzhen University
Observed institution: Shenzhen University
ORCID: 0009-0007-9282-5745
Observed ORCID: 0009-0007-9282-5745
OpenAlex ID: A5070636146
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al. · Cancer Research · 15
Supplementary Figure 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Figure 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 5 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Materials and Methods from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Materials and Methods from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Table 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Table 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 6 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Figure 6 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Table 5 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Works count: 60
Citation count: 15
H-index: 1
I10-index: 1
Year
Topic
Type